We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:3529P
GW Pharmaceuticals PLC
03 September 2003
G W Pharmaceuticals plc ("The Company")
Pursuant to the exercise by Adrian Bradshaw of a warrant over 108,750 new
ordinary shares of 0.1p each in the Company ("New Ordinary Shares") at a price
of 103p per share, the Company has today issued and allotted the New Ordinary
Shares and applied for them to be admitted to the Alternative Investment Market
(AIM) of the London Stock Exchange.
Such admission is expected to become effective on Monday 8th September 2003.
3rd September 2003.
This information is provided by RNS
The company news service from the London Stock Exchange
END
LISBUGDCCBGGGXX
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
